1.Dong, X, Li H, Pei M, Tan J, Chen G, Li S, Xie Z, Wang Q, Wang G, Chen Y, Wang C. 2022. Analgesic effects of nerve growth factor-directed monoclonal antibody on diabetic neuralgia in an animal model. FEBS Open Bio. doi:10.1002/2211-5463.13410. 

2.Liu X, Zhou T, Wang Y, Pei M, Chen YL, Wang G, Chu W, Wang Q, Wang C. 2022. TROP2 as patient-tailoring but not prognostic biomarker for breast cancer. OncoTargets and Therapy. 15: 509–520. 

3.Liang Z, Tan J, Xie Z, Chen G, Liu G, Lin Yuan, Wang K, Ding H, Qiu H, Wang C. 2022. Chemotherapy-induced peripheral neuropathy is alleviated by NGF monoclonal antibody. Acta Pharmacol Sin 0:1-7. 

4.Chu W, Xu H, Wang Y, Xie Y, Chen YL, Tan X, Huang C, Wang G, Wang Q, Luo W, Xia N, Geng M, Xie Z, Wang C. 2022. HER2/PD-1 bispecific antibody in IgG4 subclass with superior antitumor activities. Clinical and Translational Medicine 12：e791.

5.Mu S, Liang Z, Wang1 Y, Chu1 W, Chen Y, Wang Q, Wang G, Wang C. 2022. PD-L1/TIGIT bispecific antibody showed survival advantage in animal model. Clinical and Translational Medicine. 12:e754. 

6.Ou J, Zhang Y, Wang Y, Zhang Z, Wei H, Yu J, Wang Q, Wang G, Zhang B, Wang C. 2022. ACE2-targeting antibody suppresses sars-cov-2 omicron and delta variants. Signal Transduction and Targeted Therapy.7:43.

7.Dai X, Wang Y, Li X, Pei M, Dong X, Gold BG, Zhong Y,Vandenbark, AA, Neve KA, Offner H, Wang G, Wang C. 2022. Tyrphostin A9 protects axons in experimental autoimmune encephalomyelitis through activation of ERKs. Life Science, 94:120383.

8.Chen YL, Cui Y, Liu X, Liu G, Dong X, Tang L, Hung Y, Wang C, Feng MQ. 2022. Bispecific antibody targeting her2 and pd-l1 inhibits tumor growth with superior efficacy. J Biol Chem. 297：101420 

9.Pei M., Liu T, Ouyang L, Sun J, Deng X, Sun X, Wu W, Huang P, Chen Y, Tan X, Liu X, Zhu P, Liu Y, Wang D, Wu J, Wang Q, Wang G, Gong L, Qin Q, Wang C. 2021. Enzyme-linked immunosorbent assays for quantification of mmae-conjugated ADCs and total antibodies in cynomolgus monkey sera. Journal of Pharmaceutical Analysis. https://www.sciencedirect.com/ science/ article/ pii/ S2095177921001350.

10.Chen, Y., Zhang, YN., Yan, R. Wang, G., Zhang Y., Zhang Z.R., Li Y, Ou J., Chu, W., Liang Z., Wang Y., Chen Y.L., Chen G., Wang Q., Zhou Q., Zhang B., Wang C. 2021. ACE2-targeting monoclonal antibody as potent and broad-spectrum coronavirus blocker. Signal Transduction and Targeted Therapy. 6, 315. 

11.Shao, T., Chen T., Chen, Y., Liu, X., Chen, Y.L., Wang, Q., Wang C. 2020. Construction of paclitaxel-based antibody drug conjugate with pegylated linker to achieve superior therapeutic index. Signal Transduction and Targeted Therapy. 15:132.

12.王春河、万亚坤、黄鹏、李佳。生物技术药物兴起与展望。《现代药物研发回顾与展望--新药研发何去何从》，白东鲁、沈竞康编，化工出版社 2019。 

13.Bodhankar, S., Wang, C., Vandenbark, A.A., and Offner, H. 2011. Estrogen-induced protection against experimental autoimmune encephalomyelitis is abrogated in the absence of B cells. Eur. J. Immunol. 41:1165

14.Wang, C., Li, Y., Proctor, T. M., Vandenbark, A. A. and Offner, H. 2010. Down-modulation of programmed death 1 alters regulatory T cells and promotes experimental autoimmune encephalomyelitis. J. Neurosci. Res. 88:7.

15.Wang, C., Dehghani, B., Li, Y., Kaler, L. J., Vandenbark, A. A., and Offner, H., 2009. Oestrogen modulates experimental autoimmune encephalomyelitis and interleukin-17 production via programmed death 1. Immunology 126:329.

16.Wang, C., Dehghani, B., Li, Y., Kaler, L. J., Proctor, T., Vandenbark, A. A. and Offner, H. 2009. Membrane estrogen receptor regulates experimental autoimmune encephalomyelitis through up-regulation of programmed death 1. J. Immunol. 182:3294.

17.Offner, H., Sinha, S., Wang, C., Burrows, G. G., and Vandenbark. A. A., 2008. Recombinant T cell receptor ligands: immunomodulatory, neuroprotective and neuroregenerative effects suggest application as therapy for multiple sclerosis. Rev. Neurosci. 19:327.

18.Wang, C., Dehghani, B., Magrisso, I. J., Rick, E. A., Bonhomme, E., Cody, D. B., Elenich, L. A., Subramanian, S., Murphy, S. J., Kelly, M. J., Rosenbaum, J. S., Vandenbark, A. A. and Offner, H. 2008. GPR30 contributes to estrogen-induced thymic atrophy. Mol. Endocrinol. 22:636.

19.Wang, C., Gold, B.G., Kaler, L.J., Yu, X., Afentoulis, M.E., Burrows G.G., Vandenbark, A.A., Bourdette, D.N., Offner, H. 2006. Antigen-specific therapy promotes repair of myelin and axonal damage in established EAE. J. Neurochem. 98: 1816.

20.Wang, C., Chou, Y. C., Rich, C. M., Link, J.M., Afentoulisa, M. E., van Noort, J. M., Wawrousekd, E. F., Offner, H., Vandenbarka, A. A. 2006. B-crystallin-reactive T cells from knockout mice are not encephalitogenic. J. Neruoimmunol. 176: 51.

21.Offner, H., Subramanian, S., Parker, S.M., Wang, C., Afentoulis, M. E., Lewis, A., Vandenbark, A. A. and Hurn, P. D. 2006. Splenic atrophy in experimental stroke is accompanied by increased Treg cells and circulating macrophages. J. Immunol. 176: 6523.

22.Offner, H., Subramanian, S., Wang, C., Afentoulis, M. E., Vandenbark, A. A., Huan, J., and Burrows, G. G. 2005. Treatment of passive EAE in SJL mice with a recombinant TCR ligand induces high levels of IL-13. J.Immunol. 175: 4103.

23.Wang, C., Buck, D. C., Yang, R, Macey, T. A., and Neve, K. A. 2005. Dopamine D2 receptor stimulation of mitogen-activated protein kinases mediated by cell type-dependent transactivation of receptor tyrosine kinases. J.Neurochem. 93: 899.

24.Chou, Y. K., Burrows, G. G., LaTocha, D., Wang, C., Subramanian, S., Bourdette, D. N., and Vandenbark, A. A. 2004. CD4 T-cell epitopes of human alpha B-crystallin. J.Neurosci.Res. 75: 516.

25.Wang, C., Mooney, J. L., Meza-Romero, R., Chou, Y. K., Huan, J., Vandenbark, A. A., Offner, H., and Burrows, G. G. 2003. Recombinant TCR ligand induces early TCR signaling and a unique pattern of downstream activation. J.Immunol. 171: 1934.

26.Vandenbark, A. A., Rich, C., Mooney, J., Zamora, A., Wang, C., Huan, J., Fugger, L., Offner, H., Jones, R., and Burrows, G. G. 2003. Recombinant TCR ligand induces tolerance to myelin oligodendrocyte glycoprotein 35-55 peptide and reverses clinical and histological signs of chronic experimental autoimmune encephalomyelitis in HLA-DR2 transgenic mice. J.Immunol. 171: 127.

27.Burrows G. G., Chou Y. K., Wang C, Chang J. W., Finn T. P., Culbertson N. E., Kim J, Bourdette D. N., Lewinsohn D. A., Lewinsohn D. M., Ikeda M, Yoshioka T, Allen C. N., Offner H, Vandenbark A. A. 2001. Rudimentary TCR signaling triggers default IL-10 secretion by human Th1 cells. J Immunol 167: 4386.

28.Wang C, Zhou D. H., Chen J, Chi Z. Q. 1999. Leucine-2-alanine enkephalin induced delta opioid receptors internalization expressed stably in CHO cells. Acta Pharmacol Sin. 20: 491.

29.Wang C, Zhou D. H., Chen Z. J., Wei Q, Chen J, Li G. F., Pei G, Chi Z. Q. 1998. The C-truncated delta-opioid receptor underwent agonist-dependent activation and desensitization. Biochem Biophys Res Commun 249: 321.

30.Wang C, Zhou D. H., Chen J, Li G. F., Pei G., Chi Z. Q. 1997. Binding properties of C-truncated delta opioid receptors. Acta Pharmacol Sin 18: 337.

31.Wei Q, Zhou D. H., Shen Q. X., Wang C, Pei G, Chi Z. Q. 1998. Human mu-opioid receptor overexpressed in baculovirus system and its pharmacological characterizations. Acta Pharmacol Sin 19: 218.

32.Zhu X. L., Wang C, Chen Z. J., Wu Y. L., Zhou D. H., Pei G. 1997. The carboxyl terminus mouse delta-opioid receptor is not required for agonist-dependent activation. Biochem Biophys Res Commun 232: 513.